• No results found

How to improve duration and quality of life in men?

N/A
N/A
Protected

Academic year: 2021

Share "How to improve duration and quality of life in men?"

Copied!
1
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Transl Androl Urol 2018;7(1):3 tau.amegroups.com

© Translational Andrology and Urology. All rights reserved.

This question plays a central role in prostate cancer research and was the reason for the initiation of the European Randomized Study of Screening for Prostate Cancer (ERSPC) and its spinoff the Prostate Cancer Research International Active Surveillance (PRIAS) study.

It is a great honor for me as a retired urologist and former coordinator of the ERSPC to write a brief introduction to this comprehensive overview of the present status of our knowledge concerning screening and active surveillance of prostate cancer. My cooperation with the lead author of this focused issue, Professor Monique Roobol, PhD, who started her career in urology on September 15, 1991 was an essential element in the development and conduct of the ERSPC and PRIAS trials.

It is very satisfying to be aware that important unresolved questions concerning the early diagnosis and management of prostate cancer can still be addressed by results derived from our trials. This will hopefully result in a level of understanding of the advantages and disadvantages of screening for prostate cancer which will lead to the worldwide reduction of the incidence and mortality of this disease at an acceptable rate of side effects. In many countries prostate cancer is the second or third most frequent cause of death from cancer in males.

The present overview summarizes relevant information which can be considered a milestone in reaching this goal. Acknowledgements

None.

Fritz H. Schröder, MD

Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands. (Email: secr.schroder@erasmusmc.nl)

doi: 10.21037/tau.2018.01.02 Conflicts of Interest: The author has no conflicts of interest to declare.

View this article at: http://dx.doi.org/10.21037/tau.2018.01.02

Preface

How to improve duration and quality of life in men?

3

Cite this article as:Schröder FH. How to improve duration and quality of life in men? Transl Androl Urol 2018;7(1):3. doi: 10.21037/tau.2018.01.02

Referenties

GERELATEERDE DOCUMENTEN

implies patients still can have an active role in the process leading to the treatment decision, but prefer to leave to actual decision to the clinician. We did not observe

We used data from the longitudinal, population-based Prostate Cancer Outcomes Study (PCOS) [12] to assess the relationship of prevalent and incident diabetes to general and

Deze groep bedrijven maakt (1987) in de veenweidegemeenten 83,5% uit van alle agrarische bedrijven, in de overige weidegemeenten 80Z en in de overige gemeenten 84%. Er bestaan in

provisions and regulations concerning part-time farming. Moreover, due to their invisibility women have a specific position in the agricultural sector, which differs from the

Since what constitutes knowledge of the world for us is determined both by states of the world (it must fit the constraints of those external objects and properties) and by the

2,  the  associations  between  physical,  psychological  and  social  frailty  and  HRQoL  among  community‐dwelling  older  people  are  studied.  In  Chapter 

Vaak wordt de term voorbehouden aan het klinisch beeld waarbij sprake is van verhoogde cardiale enzymen in het bloed al dan niet in combinatie met afwijkingen op het ECG

Left ventricular assist device (LVAD) therapy can be successful in lowering PAPs by unloading the left ventricle, which will aid in the treatment of PH caused by left-sided